Statistics

Total Visits

Views
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months94

File Visits

Downloads
Casado et al. - 2015 - Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontl.pdf11

Select a period of time:

Number of views in the range

Views
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months31

Number of downloads in the range

Downloads
Casado et al. - 2015 - Switching to second‐generation tyrosine kinase inhibitor improves the response and outcome of frontl.pdf9

Views

Views
December 20250
January 20265
February 20260
March 20268
April 20262
May 20265
June 202611
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    0
  • January 2026
    0
  • February 2026
    0
  • March 2026
    0
  • April 2026
    3
  • May 2026
    3
  • June 2026
    3
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Netherlands4
Finland2
Germany2
Argentina1
Australia1
Canada1
Spain1
France1
Morocco1
 

Top countries by downloads

Downloads
United States5
Spain2
 

Top cities views

Views
Groningen4
Frankfurt am Main2
Helsinki2
Council Bluffs2
Ames1
Fes1
Fort McMurray1
González Catán1
Louisville1
Memphis1
 

Top cities by downloads

Downloads